<?xml version="1.0" encoding="UTF-8"?>
<QuestionnaireResponse xmlns="http://hl7.org/fhir">
  <resourceType value="QuestionnaireResponse" />
  <id value="QuestionnaireResponse" />
  <meta>
    <versionId value="1" />
    <lastUpdated value="2025-11-20T22:30:00Z" />
    <profile value="http://hl7.org/fhir/uv/rtq/StructureDefinition/rtq-questionnaireresponse" />
  </meta>
  <identifier>
    <system value="http://hl7.org/fhir/uv/brr/identifier/qa-request" />
    <value value="ID001" />
  </identifier>
  <identifier>
    <system value="https://ema.europa.eu/procedure-number" />
    <value value="EMEA/H/C/005432/II/0023" />
  </identifier>
  <text>
    <status value="generated" />
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>Dear Assessment Team,</p>
      <p>Please find below the structured responses to the List of Questions issued on 2025-05-20
        for the Type II variation (EMEA/H/C/005432/II/0023) concerning ExampleDrug 10 mg Tablets.</p>
      <p>Yours sincerely,<br />Dr. John Doe<br />Head of Regulatory Affairs<br />SynthPharma AG</p>
    </div>
  </text>

  <questionnaire value="questionnaire_ID001" />
  <status value="completed" />
  <subject>
    <reference value="MedicinalProductDefinition/MedicinalProduct-ExampleDrug" />
    <display value="ExampleDrug 10 mg Tablets" />
  </subject>

  <!-- Author = Regulatory Authority (EMA) – full inline Organization -->
  <author>
    <type value="Organization" />
    <identifier>
      <system value="https://ema.europa.eu/organization-id" />
      <value value="EMA" />
    </identifier>
    <name value="European Medicines Agency" />
    <contact>
      <name>
        <family value="Doe" />
        <given value="Jane" />
        <prefix value="Dr." />
      </name>
      <telecom>
        <system value="phone" />
        <value value="+31-88-781-6000" />
        <use value="work" />
      </telecom>
      <telecom>
        <system value="email" />
        <value value="jane.doe@ema.example.eu" />
        <use value="work" />
      </telecom>
      <telecom>
        <system value="url" />
        <value value="https://www.ema.europa.eu" />
      </telecom>
      <address>
        <use value="work" />
        <line value="Domenico Scarlattilaan 6" />
        <city value="Amsterdam" />
        <postalCode value="1083 HS" />
        <country value="NL" />
      </address>
    </contact>
  </author>

  <!-- Source = Marketing Authorisation Holder (SynthPharma AG) – full inline Organization -->
  <source>
    <type value="Organization" />
    <identifier>
      <system value="https://www.zefix.ch/en/SwissCompanyRegistry/UID" />
      <value value="CHE-123.456.789" />
    </identifier>
    <name value="SynthPharma AG" />
    <contact>
      <name>
        <family value="Doe" />
        <given value="John" />
        <prefix value="Dr." />
      </name>
      <telecom>
        <system value="phone" />
        <value value="+41-44-123-45-67" />
        <use value="work" />
      </telecom>
      <telecom>
        <system value="email" />
        <value value="john.doe@synthpharma.ch" />
        <use value="work" />
      </telecom>
      <telecom>
        <system value="url" />
        <value value="https://www.synthpharma.ch" />
      </telecom>
      <address>
        <use value="work" />
        <line value="Industriestrasse 12" />
        <city value="Basel" />
        <postalCode value="4056" />
        <country value="CH" />
      </address>
    </contact>
  </source>

  <authored value="2025-06-25T14:00:00+02:00" />

<item>
  <linkId value="2.4.1"/>

  <!-- Rich version of the QUESTION / LABEL (replaces .text) -->
  <extension url="http://hl7.org/fhir/StructureDefinition/rendering-xhtml">
    <valueXhtml>
      <div xmlns="http://www.w3.org/1999/xhtml">
        <h3>2.4.1 Summary of clinical pharmacology studies</h3>
        <p>Provide a tabular overview to include the following information for each study:</p>
        <ul>
          <li>Study identifier</li>
          <li>Objectives</li>
          <li>Design</li>
          <li>Population</li>
          <li>Key results</li>
        </ul>
        <table border="1">
          <thead>
            <tr><th>Study ID</th><th>Phase</th><th>Primary endpoint</th></tr>
          </thead>
          <tbody>
            <tr><td>ABC-101</td><td>Phase 1</td><td>Safety and PK</td></tr>
          </tbody>
        </table>
      </div>
    </valueXhtml>
  </extension>

  <!-- One or more answers – each can have its own rich XHTML (replaces answer.value[x]) -->
  <answer>
    <extension url="http://hl7.org/fhir/StructureDefinition/rendering-xhtml">
      <valueXhtml>
        <div xmlns="http://www.w3.org/1999/xhtml">
          <p>Clinical pharmacology studies demonstrated dose-proportional pharmacokinetics across the dose range of 100–800 mg.</p>
          
          <h4>Key pharmacokinetic parameters (single dose)</h4>
          <table border="1">
            <thead>
              <tr><th>Dose</th><th>Cmax (ng/mL)</th><th>AUC0-∞ (ng·h/mL)</th><th>t½ (h)</th></tr>
            </thead>
            <tbody>
              <tr><td>100 mg</td><td>1,250</td><td>12,400</td><td>8.2</td></tr>
              <tr><td>400 mg</td><td>5,100</td><td>48,900</td><td>8.5</td></tr>
              <tr><td>800 mg</td><td>10,800</td><td>102,300</td><td>8.7</td></tr>
            </tbody>
          </table>
          
          <p><b>Figure 1:</b> Mean plasma concentration-time profiles</p>
          <img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAA..." alt="PK profile"/>
        </div>
      </valueXhtml>
    </extension>
  </answer>

</item>

</QuestionnaireResponse>